microRNA 548an (MIR548AN)

microRNA 548an (MIR548AN) is a member of the miR-548 microRNA family, which is a primate-specific, poorly conserved family of non-coding RNAs. Like other microRNAs, MIR548AN is thought to regulate gene expression post-transcriptionally by binding to complementary sequences on target mRNAs, leading to their degradation or translational repression[2]. The miR-548 family is implicated in processes such as cell proliferation, apoptosis, migration, and invasion, especially in cancer biology[1][2]. Although some family members act as tumor suppressors or promoters depending on context, MIR548AN itself has not been specifically characterized as a direct therapeutic target, biomarker, or drug target. There are no approved drugs or clinical tools that act directly on MIR548AN or the broader miR-548 family as therapeutic targets at present. Its primary biological significance arises from its role—shared by many microRNAs—in the complex regulation of cellular transcriptomes and, potentially, disease pathogenesis via gene silencing mechanisms. Notes on ambiguity and limitations: - There is limited published information directly on MIR548AN; most data refer to the broader miR-548 family. - The miR-548m member has been studied in detail regarding breast cancer and EMT, but not MIR548AN specifically[1]. - No evidence was found that MIR548AN itself is a therapeutic "target" in the conventional sense—rather, it is a regulatory RNA with disease association through gene expression effects. If strict target eligibility is required (e.g., for druggability): - MIR548AN would not be considered a conventional therapeutic target such as a receptor, enzyme, transporter, or similar protein. - Its main research relevance is as a biomolecule involved in gene regulation and potentially disease pathology at the RNA level[1][2].

Other names

hsa-mir-548anMIR548ANmiR-548an

Not applicable; acts through regulation of mRNA by RNA interference, not via drug binding